No description
-
2022 (v1)PublicationUploaded on: February 14, 2024
-
2023 (v1)Publication
No description
Uploaded on: February 14, 2024 -
2017 (v1)Publication
Determining risk for recurrence or survival after curative resection or ablation in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) is important for stratifying patients according to expected outcomes in future studies of adjuvant therapy in the era of direct-acting antivirals (DAAs). The aims of this meta-analysis...
Uploaded on: April 14, 2023 -
September 28, 2022 (v1)Publication
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent, yet largely underappreciated liver condition which is closely associated with obesity and metabolic disease. Despite affecting an estimated 1 in 4 adults globally, NAFLD is largely absent on national and global health agendas. Methods: We collected data from 102...
Uploaded on: March 24, 2023 -
September 20, 2022 (v1)Publication
Background Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent condition that requires a comprehensive and coordinated response across sectors and disciplines. Aims In the absence of a multisectoral framework to tackle this condition, we developed one using the sustainable development goals (SDGs) as the basis for converging...
Uploaded on: March 24, 2023